Dewey Steadman | executive |
Martine Rothblatt | executive |
Michael Benkowitz | executive |
Roanna Clarissa Ruiz | analyst |
Ashwani Verma | analyst |
Leigh Peterson | executive |
Jessica Fye | analyst |
Joseph Thome | analyst |
Hartaj Singh | analyst |
Andreas Argyrides | analyst |
James Edgemond | executive |
Good morning, and welcome to the United Therapeutics Corporation Fourth Quarter 2023 Earnings Webcast. My name is David, and I will be your conference operator today. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference over to Dewey Steadman, Head of Investor Relations at United Therapeutics.
Thank you, Dave, and good morning.